KIR3DL1 and non-Hodgkin lymphoma: Data also showed that interaction of HLA-Bw4–80I with the inhibitory KIR3DL1 receptor may influence MC development; thus, individuals with an HLA-Bw4–80I+ KIR3DL1+ genotype would have a low risk of developing NHL (Fig. 4).